Compare Aurora Cannabis Inc (ACB) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

Aurora Cannabis IncTrade

Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Aurora Cannabis Inc vs Citius Pharmaceuticals Inc — how do they compare? Aurora Cannabis Inc trades at $3.52 (market cap $223.59M), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Aurora Cannabis Inc is far larger — about 11.2× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.

	ACB	CTXR
Market Cap	$223.59M	$20.01M
Sector	Health	Health
52-Week High	$6.23	$1.82
52-Week Low	$2.58	$0.48
Enterprise Value	$168.09M	$16.23M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ACB

Aurora Cannabis reviews unsolicited $4/share takeover bid from Curaleaf, no decision yet.PRNewsWire · 21 hours agoNeutral Curaleaf launches hostile bid to acquire Aurora Cannabis at $4 per share, offering shares plus cash.Proactive Investors · 21 hours agoBullish Curaleaf offers to buy Aurora Cannabis with a 45% premium, aiming to create a leading global cannabis platform.PRNewsWire · 1 day agoBullish View details →

CTXR

Citius Oncology appoints Jonathan Peri as new independent board member to strengthen governance.PRNewsWire · 5 hours agoBullish View details →

About Aurora Cannabis Inc

Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.